The Ministry of Health and Family Welfare prohibited the manufacture and sale of these medicines after the Drugs Technical Advisory Board said these medicines could harm consumers
As many as 328 population Fixed Dose Combination (FDC) medicines will no longer be available in the market. On September 12, 2018, the Ministry of Health and Family Welfare prohibited the manufacture and sale of these medicines. Six more FDCs have been restricted.
This order has been given after the Drugs Technical Advisory Board submitted its report to the Centre saying there is no therapeutic justification for the ingredients contained in 328 FDCs and that these medicines could harm consumers. The Board recommended that these drugs be prohibited under section 26 A of the Drugs and Cosmetics Act, 1940 in the larger public interest. The interaction of ingredients used in FDCs are not well studied and one drug can hamper the absorption of the other or aggravate/ suppress the effect of the other.
Companies produce them to make profits. These drugs help pharma companies circumvent the Drug Price Control Order of Government which puts a ceiling on the prices of essential drugs.
In March, 2016, the ministry had prohibited 349 FDCs the matter was contested by the affected manufacturers in various High Courts and the Supreme Court of India. Decision on 15 of these drugs is pending.
According to media reports, the banned drugs include Saridon, Panderm, Gluconorm, Lupidiclox and Taxim AZ. For example, Saridon contains analgesics propyphenazone and paracetamol and the stimulant caffeine which is considered irrational combination.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
India Environment Portal Resources :